New MRI technique may spot brain tumor recurrence without a biopsy
NCT ID NCT04373720
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 33 times
Summary
This study tests whether magnetic resonance elastography (MRE), a special MRI that measures tissue stiffness, can tell the difference between radiation necrosis (scarring from radiation) and recurrent glioma (tumor regrowth) in people who have already been treated for brain cancer. About 80 adults with a history of glioma will undergo MRE and standard MRI. The goal is to see if stiffness measurements can accurately distinguish the two conditions, which could lead to better diagnosis and treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a non-invasive way to distinguish between tumor regrowth and radiation damage, helping doctors choose the right treatment without unnecessary surgery.
What could go wrong
This is a small early-stage study, so results may not apply to all patients. The technique may not reliably tell the difference in all cases, and further research will be needed.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.